Skip to Main Content

106931 Apr 2026

An eLife report identifies that doubling the dolutegravir dosage may reduce the viral reservoir in HIV patients, with peer reviewers characterizing the finding as a "solid" indication. This study suggests treatment intensification can lower intact HIV DNA levels within three months, although the effect was not consistent across all participants. Read the full study at eLife . AI responses may include mistakes. Learn more

Sign in with Email

or

Continue with GoogleContinue with FacebookContinue with Apple

By creating an account, you acknowledge that PBS may share your information with our member stations and our respective service providers, and that you have read and understand the Privacy Policy and Terms of Use.

Are you sure you want to remove null from My List?